These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39027785)

  • 1. Utilizing Alcohol Septal Ablation for Mitigating Left Ventricular Outflow Tract Obstruction in Cardiac Amyloidosis: A Case Report.
    Girgis K; Feinberg A; Retcho D; Elias T; George A; Gonzalez Garcia G; Beshai R; Chennu G; Patel R; Cohen M
    Cureus; 2024 Jun; 16(6):e62633. PubMed ID: 39027785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alcohol septal ablation for left ventricular outflow tract obstruction in cardiac amyloidosis: New indication for an established therapy.
    Fanta LE; Ewer SM; Gimelli G; Reilly NM
    Catheter Cardiovasc Interv; 2022 Nov; 100(5):910-914. PubMed ID: 36153647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment of regression of left ventricular hypertrophy following alcohol ablation of the interventricular septum in patients with hypertrophic cardiomyopathy with left ventricular outflow tract obstruction.
    Dąbrowski M; Chojnowska L; Małek L; Spiewak M; Kuśmierczyk B; Koziarek J; Klisiewicz A; Miśko J; Witkowski A
    Kardiol Pol; 2012; 70(8):782-8. PubMed ID: 22933209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Looking back on 15 years of ultrasound-guided alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Vermaete I; Dujardin K; Stammen F
    Acta Cardiol; 2020 Oct; 75(6):483-491. PubMed ID: 31204591
    [No Abstract]   [Full Text] [Related]  

  • 5. Treating a Structural Heart Disease Using a Non-structural Approach: Role of Cardiac Pacing in Hypertrophic Cardiomyopathy.
    Albano BB; Fadreguilan EC; Chua JM; Ho J; Medrano AB
    Cardiol Res; 2017 Feb; 8(1):20-25. PubMed ID: 28275421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short- and long-term outcome after alcohol septal ablation in obstructive hypertrophic cardiomyopathy: Experience of a reference center.
    Aguiar Rosa S; Fiarresga A; Galrinho A; Cacela D; Ramos R; de Sousa L; Gonçalves A; Bernardes L; Patrício L; Branco LM; Ferreira RC
    Rev Port Cardiol (Engl Ed); 2019 Jul; 38(7):473-480. PubMed ID: 31495717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alcohol septal ablation markedly reduces energy loss in hypertrophic cardiomyopathy with left ventricular outflow tract obstruction: A four-dimensional flow cardiac magnetic resonance study.
    Dai Z; Iguchi N; Takamisawa I; Takayama M; Nanasato M; Kanisawa M; Mizuno N; Miyazaki S; Isobe M
    Int J Cardiol Heart Vasc; 2021 Dec; 37():100886. PubMed ID: 34692989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol Septal Ablation to Prevent Left Ventricular Outflow Tract Obstruction During Transcatheter Mitral Valve Replacement: First-in-Man Study.
    Wang DD; Guerrero M; Eng MH; Eleid MF; Meduri CU; Rajagopal V; Yadav PK; Fifer MA; Palacios IF; Rihal CS; Feldman TE; O'Neill WW
    JACC Cardiovasc Interv; 2019 Jul; 12(13):1268-1279. PubMed ID: 31272671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two Hearts at Risk: Emergency Alcohol Septal Ablation in a Pregnant Woman With Decompensated HOCM.
    Gi WT; Amr A; Sedaghat-Hamedani F; Kayvanpour E; Mohr I; Meder M; Shirvani Samani O; Fluhr H; Katus HA; Meder B
    JACC Case Rep; 2020 Jan; 2(1):139-144. PubMed ID: 34316982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of immediate decrease in ventricular septal strain after alcohol septal ablation for obstructive hypertrophic cardiomyopathy to long-term reduction in left ventricular outflow tract pressure gradient.
    van Ramshorst J; Mollema SA; Delgado V; van der Wall EE; Schalij MJ; Atsma DE; Bax JJ
    Am J Cardiol; 2009 Jun; 103(11):1592-7. PubMed ID: 19463521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time to significant gradient reduction following septal balloon occlusion predicts the magnitude of final gradient response during alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Almasood A; Garceau P; Woo A; Rakowski H; Schwartz L; Overgaard CB
    JACC Cardiovasc Interv; 2011 Sep; 4(9):1030-4. PubMed ID: 21939945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of left ventricular mass, left atrial size, and N-terminal pro-B-type natriuretic peptide level following alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Dąbrowski M; Kukuła K; Kłopotowski M; Bekta P; Śpiewak M; Mazurkiewicz Ł; Tyczyński P; Orczykowski M; Parma R; Witkowski A
    Kardiol Pol; 2019; 77(2):181-189. PubMed ID: 30566209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term results of alcohol septal ablation as a bail-out strategy to treat severe left ventricular outflow tract obstruction after transcatheter mitral valve replacement in patients with severe mitral annular calcification.
    Guerrero M; Wang DD; Himbert D; Urena M; Pursnani A; Kaddissi G; Iyer V; Salinger M; Chakravarty T; Greenbaum A; Makkar R; Vahanian A; Feldman T; O'Neill W
    Catheter Cardiovasc Interv; 2017 Dec; 90(7):1220-1226. PubMed ID: 28266162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous alcohol septal ablation for hypertrophic obstructive cardiomyopathy: technical review and long-term clinical and echocardiographic outcomes.
    Leal S; Galeote G; Jiménez-Valero S; Sánchez-Recalde A; Salinas P; Ruiz AS; Orbe LC; Dominguéz F; Moreno R; López-Sendón JL
    Rev Port Cardiol; 2012 May; 31(5):363-71. PubMed ID: 22482474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preemptive alcohol septal ablation prior to transcatheter mitral valve replacement.
    Wong N; Lim DS; Yount K; Yarboro L; Ailawadi G; Ragosta M
    Catheter Cardiovasc Interv; 2023 Dec; 102(7):1341-1347. PubMed ID: 37855165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic left ventricular outflow tract obstruction in senile cardiac amyloidosis.
    Mookadam F; Haley JH; Olson LJ; Cikes M; Mookadam M
    Eur J Echocardiogr; 2006 Dec; 7(6):465-8. PubMed ID: 16236554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy.
    Flores-Ramirez R; Lakkis NM; Middleton KJ; Killip D; Spencer WH; Nagueh SF
    J Am Coll Cardiol; 2001 Jan; 37(1):208-14. PubMed ID: 11153740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol septal ablation in hypertrophic cardiomyopathy utilizing a longitudinal 17-year study (mean 10.8). Observation follow-ups taken at a single medical centre.
    Wojtarowicz A; Kornacewicz-Jach Z
    Cardiol J; 2017; 24(2):125-130. PubMed ID: 27734458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syncope from dynamic left ventricular outflow tract obstruction simulating hypertrophic cardiomyopathy in a patient with primary AL-type amyloid heart disease.
    Velazquez-Ceceña JL; Lubell DL; Nagajothi N; Al-Masri H; Siddiqui M; Khosla S
    Tex Heart Inst J; 2009; 36(1):50-4. PubMed ID: 19436787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed reversibility of complete atrioventricular block: cardio-biliary reflex after alcohol septal ablation in a patient with hypertrophic obstructive cardiomyopathy.
    Fang S; Gao L; Yang F; Gong YJ
    BMC Cardiovasc Disord; 2021 Aug; 21(1):372. PubMed ID: 34344308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.